通过促进早期I型干扰素反应,使瘤对免疫疗法的敏感化,可以使表皮质扩散
Sadeem Qdaisat1,2, Brandon Wummer1, Brian D Stover3
1Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
Nature biomedical engineering
|July 18, 2025
概括
早期I型干扰素反应是癌症免疫治疗成功的关键,即使在困难的瘤中也是如此. 通过装载RNA的颗粒来增强这些反应,可以增强免疫力,促进瘤的排斥,从而提供新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 病毒学 病毒学
背景情况:
- 癌症免疫疗法,包括免疫检查点抑制剂,通常依赖于向新表位,有利于具有高突变负担的瘤.
- 由于缺乏有效的免疫反应,免疫性较差的瘤经常对当前的免疫疗法表现出抵抗力.
研究的目的:
- 调查I型干扰素早期反应在调解免疫检查点抑制剂成功中的作用.
- 探索增强干扰素反应的方法,以克服在免疫性较差的瘤中的免疫疗法耐药性.
- 为了确定增强干扰素反应是否可以诱导表皮层扩散并改善抗瘤免疫力.
主要方法:
- 利用癌症免疫治疗的小鼠模型.
- 给药的脂质颗粒装载着编码瘤非特异性抗原的RNA,以增强I型干扰素反应.
- 从敏感瘤转移到耐药瘤的免疫反应.
- 评估瘤免疫力,表皮质扩散,以及防止瘤复发的保护.
主要成果:
- 早期的I型干扰素反应被发现可以调解免疫检查点抑制剂的成功,并促进在免疫性不良的瘤中表皮质扩散.
- 系统的RNA加载脂质颗粒有效地增强了这些关键的干扰素反应.
- 免疫疗法敏感瘤的免疫反应可转移到耐药瘤,从而提高免疫力和保护.
- 通过增强干扰素信号来恢复损伤反应,使治疗不耐药瘤的表皮质扩散和自我放大免疫力成为可能.
结论:
- 癌症免疫疗法的疗效受到早期I型干扰素信号的显著影响.
- 增强I型干扰素反应可以通过诱导表皮层扩散和增强抗瘤免疫力来克服瘤中的免疫疗法抵抗.
- 这种方法有望治疗更广泛的癌症,包括目前不耐免疫治疗的癌症.
相关概念视频
01:27Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
01:30Cancer Vaccines
516
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
516
01:27Cytotoxic T Cells-mediated Immune Response
2.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.2K